Physician

Charles F Moore, M.D.

According to 2025 Medicare claims, Charles Moore, M.D. (NPI: 1740209253) practices rheumatology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Clark, IN. This provider's primary affiliated billing organization is LAKE CUMBERLAND RHEUMATOLOGY, PLLC (NPI: 1619117058; TIN: 264240766) and primary practice location at 47150-9562.

Moore's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 270 traditional Medicare patients, billed 21,277 HCPCS/CPT codes, and received $291,333 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,462 prescription claims across 306 beneficiaries totaling $4,121,934 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2020 DME data shows 39 claims. Open Payments data shows 32 records totaling $593. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $17,269 to $291,333. Similarly, Part D prescription costs have risen steadily, from $525,882 to $4,121,934. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	174	289	$17,269
2016	283	527	$31,788
2017	331	805	$61,972
2018	272	663	$56,376
2019	198	750	$39,612
2020	247	995	$44,904
2021	225	834	$41,017
2022	198	753	$34,645
2023	191	543	$28,501
2024	270	21,277	$291,333

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	131	649	$525,882
2016	186	988	$1,008,022
2017	227	621	$709,207
2018	146	292	$93,307
2019	190	779	$834,247
2020	252	1,260	$1,809,555
2021	303	1,512	$2,915,338
2022	297	1,610	$3,835,558
2023	297	1,720	$5,153,527
2024	306	1,462	$4,121,934

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	24	129	$3,041
2018	22	192	$4,096
2019	N/R	65	$1,986
2020	N/R	39	$1,199
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	93	93	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	104	143	$65
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	31	39	$49
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	34	39	$45
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	103	136	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	204	6,232	$1,426,045
Rinvoq	Upadacitinib	148	4,740	$942,698
Enbrel Sureclick	Etanercept	101	3,024	$753,906
Enbrel Mini	Etanercept	18	504	$129,516
Cosentyx Sensoready Pen	Secukinumab	15	442	$127,689

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$593	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles F. Moore, M.D.?

Tedicare shows public-source Medicare data for Charles F. Moore, M.D. (NPI 1740209253), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles F. Moore, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles F. Moore, M.D.?

Charles F. Moore, M.D. is linked to LAKE CUMBERLAND RHEUMATOLOGY, PLLC (billing NPI 1619117058) in the available physician profile data.

Does Charles F. Moore, M.D. have Open Payments data?

Charles F. Moore, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.